Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
暂无分享,去创建一个
M. Massari | G. Missale | C. Ferrari | P. Andreone | P. Fisicaro | T. Giuberti | S. Urbani | L. Ravanetti | A. Cavalli | C. Valdatta | C. Vandelli | E. Loggi